We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$2.63B
AUM Growth
+$217M
Cap. Flow
+$58.3M
Cap. Flow %
2.22%
Top 10 Hldgs %
32.98%
Holding
947
New
185
Increased
338
Reduced
311
Closed
89

Sector Composition

Rank Sector Weight
1 Healthcare 20.15%
2 Technology 14.41%
3 Financials 7.34%
4 Consumer Discretionary 5.99%
5 Industrials 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
776
Ford
F
$55.7B
$166K 0.01%
15,324
+1,242
+9% +$12.6K
RLJ icon
777
RLJ Lodging Trust
RLJ
$1.69B
$155K 0.01%
+21,272
New +$153K
COUR icon
778
Coursera
COUR
$1.54B
$147K 0.01%
16,833
+6,112
+57% +$50.1K
SAGE
779
DELISTED
Sage Therapeutics
SAGE
$147K 0.01%
16,095
-4,814
-23% -$35.4K
RGNX icon
780
Regenxbio
RGNX
$708M
$143K 0.01%
17,407
+6,992
+67% +$58.5K
NOV icon
781
NOV
NOV
$7B
$142K 0.01%
11,404
-12,229
-52% -$154K
TROX icon
782
Tronox
TROX
$1.04B
$142K 0.01%
+27,922
New +$152K
DBRG icon
783
DigitalBridge
DBRG
$2.95B
$140K 0.01%
+13,479
New +$129K
NFJ
784
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.43B
$139K 0.01%
11,193
CFFN icon
785
Capitol Federal Financial
CFFN
$1.1B
$138K 0.01%
22,573
+5,238
+30% +$29.6K
BCRX icon
786
BioCryst Pharmaceuticals
BCRX
$2.4B
$126K ﹤0.01%
14,079
-5,718
-29% -$53.3K
PLTK icon
787
Playtika
PLTK
$1.12B
$125K ﹤0.01%
26,465
+329
+1% +$1.62K
FLNC icon
788
Fluence Energy
FLNC
$2.44B
$120K ﹤0.01%
17,950
-487
-3% -$2.32K
BDJ icon
789
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$120K ﹤0.01%
13,458
ATEC icon
790
Alphatec Holdings
ATEC
$1.44B
$118K ﹤0.01%
10,646
+326
+3% +$3.74K
HLIT icon
791
Harmonic Inc
HLIT
$1.28B
$116K ﹤0.01%
+12,262
New +$112K
RITM icon
792
Rithm Capital
RITM
$5.69B
$116K ﹤0.01%
+10,283
New +$113K
MAX icon
793
MediaAlpha
MAX
$821M
$111K ﹤0.01%
+10,175
New +$98.2K
SANA icon
794
Sana Biotechnology
SANA
$980M
$108K ﹤0.01%
39,564
+22,005
+125% +$45.4K
ARDX icon
795
Ardelyx
ARDX
$997M
$106K ﹤0.01%
26,962
-10,125
-27% -$41.8K
SHLS icon
796
Shoals Technologies Group
SHLS
$1.5B
$104K ﹤0.01%
24,517
+5,320
+28% +$23.1K
MEI icon
797
Methode Electronics
MEI
$592M
$103K ﹤0.01%
+10,810
New +$79.4K
PTEN icon
798
Patterson-UTI
PTEN
$3.76B
$102K ﹤0.01%
17,246
-13,380
-44% -$80.6K
XPRO icon
799
Expro Ltd
XPRO
$1.91B
$89.8K ﹤0.01%
+10,449
New +$88.7K
RLAY icon
800
Relay Therapeutics
RLAY
$4.33B
$85.7K ﹤0.01%
+24,758
New +$73.6K

Similar funds

Pallas Capital Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Pallas Capital Advisors held 947 positions worth $2.63B, up 9% from $2.41B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Pallas Capital Advisors's Q2 2025 filing shows 185 new, 338 increased, 311 reduced and 89 closed positions. Its largest new stake was Capital Group Dividend Value ETF: 163,663 shares worth $6.46M. The largest sale was Goldman Sachs ActiveBeta International Equity ETF, an estimated $19M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

  • Pallas Capital Advisors's largest Q2 2025 buy was Capital Group Dividend Value ETF: 163,663 shares worth $6.46M.
  • Pallas Capital Advisors added most to Schwab Fundamental International Large Company Index ETF in Q2 2025, an estimated $21.7M increase.
  • Pallas Capital Advisors's biggest Q2 2025 reduction was Goldman Sachs ActiveBeta International Equity ETF, cutting an estimated $19M.
  • Pallas Capital Advisors fully exited Synopsys in Q2 2025, selling an estimated $7.4M.
  • Pallas Capital Advisors's ten largest holdings make up 33% of its $2.63B portfolio in Q2 2025.
  • Pallas Capital Advisors opened 185 new positions and closed 89 in Q2 2025.
  • Pallas Capital Advisors's portfolio value rose 9% quarter-over-quarter to $2.63B.

Based on Pallas Capital Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.